BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 12142746)

  • 21. CD133 expression pattern distinguishes intraductal papillary mucinous neoplasms from ductal adenocarcinomas of the pancreas.
    Shimizu K; Itoh T; Shimizu M; Ku Y; Hori Y
    Pancreas; 2009 Nov; 38(8):e207-14. PubMed ID: 19786935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cystic papillary pattern in pancreatic ductal adenocarcinoma: a heretofore undescribed morphologic pattern that mimics intraductal papillary mucinous carcinoma.
    Kelly PJ; Shinagare S; Sainani N; Hong X; Ferrone C; Yilmaz O; Fernández-del Castillo C; Lauwers GY; Deshpande V
    Am J Surg Pathol; 2012 May; 36(5):696-701. PubMed ID: 22367300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preoperative evaluation of intraductal papillary mucinous tumors performed by pancreatic magnetic resonance imaging and correlated with surgical and histopathologic findings.
    Pilleul F; Rochette A; Partensky C; Scoazec JY; Bernard P; Valette PJ
    J Magn Reson Imaging; 2005 Mar; 21(3):237-44. PubMed ID: 15723374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preoperative diagnosis of intraductal papillary-mucinous tumors of the pancreas with attention to telomerase activity.
    Inoue H; Tsuchida A; Kawasaki Y; Fujimoto Y; Yamasaki S; Kajiyama G
    Cancer; 2001 Jan; 91(1):35-41. PubMed ID: 11148557
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor.
    Suzuki Y; Atomi Y; Sugiyama M; Isaji S; Inui K; Kimura W; Sunamura M; Furukawa T; Yanagisawa A; Ariyama J; Takada T; Watanabe H; Suda K;
    Pancreas; 2004 Apr; 28(3):241-6. PubMed ID: 15084964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraductal papillary-mucinous tumours represent a distinct group of pancreatic neoplasms: an investigation of tumour cell differentiation and K-ras, p53 and c-erbB-2 abnormalities in 26 patients.
    Sessa F; Solcia E; Capella C; Bonato M; Scarpa A; Zamboni G; Pellegata NS; Ranzani GN; Rickaert F; Klöppel G
    Virchows Arch; 1994; 425(4):357-67. PubMed ID: 7820300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Intraductal papillary mucinous neoplasm of pancreas: a clinicopathologic and immunohistochemical study of 19 cases].
    Huo Z; Yang D; Chang XY; Wan JW; Chen J
    Zhonghua Bing Li Xue Za Zhi; 2008 Oct; 37(10):670-5. PubMed ID: 19094485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biomarkers, imaging and multifocality in intraductal papillary mucinous neoplasms: relevant for decision making?
    Ansari D; Aronsson L; Andersson R
    Future Oncol; 2017 Aug; 13(20):1751-1753. PubMed ID: 28831817
    [No Abstract]   [Full Text] [Related]  

  • 29. [A case of invasive ductal carcinoma of the pancreas originating from an intraductal papillary mucinous tumor that was initially misdiagnosed as a mucinous cystic tumor].
    Yokoyama S; Sasaki Y; Hashimoto K; Takeda M; Toshiyama R; Fukuda S; Naito A; Matsumoto S; Tokuoka M; Ide Y; Matsuyama J; Morimoto T; Fukushima Y; Nomura T; Kodama K; Shiba I; Takeda M
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2149-51. PubMed ID: 23268006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of laminin-5-gamma-2 chain in intraductal papillary-mucinous and invasive ductal tumors of the pancreas.
    Fukushima N; Sakamoto M; Hirohashi S
    Mod Pathol; 2001 May; 14(5):404-9. PubMed ID: 11353049
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma.
    Maire F; Hammel P; Terris B; Paye F; Scoazec JY; Cellier C; Barthet M; O'Toole D; Rufat P; Partensky C; Cuillerier E; Lévy P; Belghiti J; Ruszniewski P
    Gut; 2002 Nov; 51(5):717-22. PubMed ID: 12377813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis.
    Adsay NV; Merati K; Andea A; Sarkar F; Hruban RH; Wilentz RE; Goggins M; Iocobuzio-Donahue C; Longnecker DS; Klimstra DS
    Mod Pathol; 2002 Oct; 15(10):1087-95. PubMed ID: 12379756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinicopathologic study of the MIB-1 labeling index (Ki67) and postoperative prognosis for intraductal papillary mucinous neoplasms and ordinary ductal adenocarcinoma.
    Takeshita A; Kimura W; Hirai I; Takasu N; Moriya T; Tezuka K; Watanabe T
    Pancreas; 2012 Jan; 41(1):114-20. PubMed ID: 22143341
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diagnosis and differential diagnosis of intraductal papillary mucinous neoplasm of pancreas].
    Ji Y; Tan YS; Zhu XZ; Zeng HY; Kuang TT; Jin DY
    Zhonghua Bing Li Xue Za Zhi; 2006 Feb; 35(2):77-81. PubMed ID: 16630480
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HMGI(Y) gene expression as a potential marker of thyroid follicular carcinoma.
    Czyz W; Balcerczak E; Jakubiak M; Pasieka Z; Kuzdak K; Mirowski M
    Langenbecks Arch Surg; 2004 Jun; 389(3):193-7. PubMed ID: 15107999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fine-needle aspiration cytology of intraductal papillary mucinous tumors of the pancreas.
    Solé M; Iglesias C; Fernández-Esparrach G; Colomo L; Pellisé M; Ginés A
    Cancer; 2005 Oct; 105(5):298-303. PubMed ID: 16015637
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct pathways of pathogenesis of intraductal oncocytic papillary neoplasms and intraductal papillary mucinous neoplasms of the pancreas.
    Basturk O; Chung SM; Hruban RH; Adsay NV; Askan G; Iacobuzio-Donahue C; Balci S; Zee SY; Memis B; Shia J; Klimstra DS
    Virchows Arch; 2016 Nov; 469(5):523-532. PubMed ID: 27591765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinction of Invasive Carcinoma Derived From Intraductal Papillary Mucinous Neoplasms From Concomitant Ductal Adenocarcinoma of the Pancreas Using Molecular Biomarkers.
    Tamura K; Ohtsuka T; Date K; Fujimoto T; Matsunaga T; Kimura H; Watanabe Y; Miyazaki T; Ohuchida K; Takahata S; Ishigami K; Oda Y; Mizumoto K; Nakamura M; Tanaka M
    Pancreas; 2016 Jul; 45(6):826-35. PubMed ID: 26646266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mixed ductal-endocrine carcinoma derived from intraductal papillary mucinous neoplasm (IPMN) of the pancreas identified by human telomerase reverse transcriptase (hTERT) expression.
    Hashimoto Y; Murakami Y; Uemura K; Hayashidani Y; Sudo T; Ohge H; Sueda T; Shimamoto F; Hiyama E
    J Surg Oncol; 2008 Apr; 97(5):469-75. PubMed ID: 18161862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy.
    Nakamura A; Horinouchi M; Goto M; Nagata K; Sakoda K; Takao S; Imai K; Kim YS; Sato E; Yonezawa S
    J Pathol; 2002 Jun; 197(2):201-10. PubMed ID: 12015744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.